Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 5,533-5,544 of 12,112
Drug study icon
CompletedNCT00282464

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Dothan
Bipolarity, DepressionOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT00141271

Geodon for depression

This study is completed in the United States. It is testing geodon for depression.

Multiple locations, including Birmingham
Bipolarity, DepressionOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT07550387

HS-10380 for schizophrenia

This study is completed in China. It is testing HS-10380 for schizophrenia.

In Shanghai
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Condition
Schizophrenia
Other study type icon
CompletedNCT01940159

Safety study of SEP-363856 in schizophrenia

This study is completed in the United States. It is testing SEP-363856 for schizophrenia.

Multiple locations, including Glendale
SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.